se of dextran in adult patient undergoing liver transplantatio

Not Applicable

• Conditions: Anaesthesiology - Other anaesthesiology; iver transplantation; Hepatic artery thrombosis; Portal vein thrombosis; Liver transplantation; Surgery - Surgical techniques; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon; Blood - Clotting disorders

• Registration Number: ACTRN12624000419561
• Lead Sponsor: Austin Health - Department of Anaesthesia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-04-05
• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Inclusion Criteria:
1. Adult patient
2. Undergoing liver transplantation surgery
3. Patient receives intravenous dextran perioperatively

Exclusion Criteria

1. Paediatric patients

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hepatic artery thrombosis[Patient medical records Pre-infusion (baseline), and data for Days 1-7 post-commencement of infusion];Portal vein thrombosis[Patient medical records Pre-infusion (baseline), and data for Days 1-7 post-commencement of infusion]

Secondary Outcome Measures

Name	Time	Method
ength of ICU Stay[Correlation with medical records At time of admission to ICU and time of discharge from ICU (to ward or time of death)];Length of hospital stay[Correlation with medical records From time of admission to time of discharge (or death, if applicable)]